Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry

INTRODUCTION: The benefits and use of low-dose corticosteroids (LDCs) in severe sepsis and septic shock remain controversial. Surviving sepsis campaign guidelines suggest LDC use for septic shock patients poorly responsive to fluid resuscitation and vasopressor therapy. Their use is suspected to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Beale, Richard, Janes, Jonathan M, Brunkhorst, Frank M, Dobb, Geoffrey, Levy, Mitchell M, Martin, Greg S, Ramsay, Graham, Silva, Eliezer, Sprung, Charles L, Vallet, Benoit, Vincent, Jean-Louis, Costigan, Timothy M, Leishman, Amy G, Williams, Mark D, Reinhart, Konrad
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911744/
https://www.ncbi.nlm.nih.gov/pubmed/20525247
http://dx.doi.org/10.1186/cc9044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911744/
https://www.ncbi.nlm.nih.gov/pubmed/20525247
http://dx.doi.org/10.1186/cc9044

Ejemplares similares